Published in Health and Medicine Week, December 19th, 2005
Teva's Azithromycin tablets are the AB-rated generic equivalent of Pfizer's antibiotic Zithromax tablets, which has annual sales of approximately $1.6 billion.
Teva is currently in patent litigation concerning this product in the U.S. District Court for the Southern District of New York.
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is pharmaceutical company that develops,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.